Publicacións nas que colabora con José María García Acuña (16)

2021

  1. Long term prognostic benefit of complete revascularization in elderly presenting with NSTEMI: Real world evidence

    Reviews in Cardiovascular Medicine, Vol. 22, Núm. 2, pp. 475-482

2020

  1. Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention

    European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770

2019

  1. Clinical impact of mineralocorticoid receptor antagonists treatment after acute coronary syndrome in the real world: A propensity score matching analysis

    European Heart Journal: Acute Cardiovascular Care, Vol. 8, Núm. 7, pp. 652-659

2018

  1. Determinants and Prognostic Impact of Heart Failure and Left Ventricular Ejection Fraction in Acute Coronary Syndrome Settings

    Revista Espanola de Cardiologia, Vol. 71, Núm. 10, pp. 820-828

  2. Temporal trends between association of evidence-based treatment and outcomes in patients with non-ST-elevation myocardial infarction

    International Journal of Cardiology, Vol. 260, pp. 1-6

2017

  1. Proposal of a novel clinical score to predict heart failure incidence in long-term survivors of acute coronary syndromes

    International Journal of Cardiology, Vol. 249, pp. 301-307

2016

  1. Alteration of platelet GPVI signaling in ST-elevation myocardial infarction patients demonstrated by a combination of proteomic, biochemical, and functional approaches

    Scientific Reports, Vol. 6

  2. Dominancia coronaria y pronóstico a largo plazo de los pacientes con infarto de miocardio con elevación del segmento ST tratado con angioplastia primaria

    Revista Espanola de Cardiologia, Vol. 69, Núm. 1, pp. 19-27

  3. Mehran contrast nephropathy risk score: Is it still useful 10 years later?

    Journal of Cardiology, Vol. 67, Núm. 3, pp. 262-267

2015

  1. Relation of contrast induced nephropathy to new onset atrial fibrillation in acute coronary syndrome

    American Journal of Cardiology, Vol. 115, Núm. 5, pp. 587-591

2014

  1. Contrast-induced nephropathy and bleeding: A bidirectional link with prognostic value in acute coronary syndrome

    International Journal of Cardiology, Vol. 176, Núm. 1, pp. 235-236

2013

  1. Dosing of iodinated contrast volume: A new simple algorithm to stratify the risk of contrast-induced nephropathy in patients with acute coronary syndrome: A New Simple Algorithm to Stratify the Risk of Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome

    Catheterization and Cardiovascular Interventions, Vol. 82, Núm. 6, pp. 888-897

  2. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction

    Revista Portuguesa de Cardiologia, Vol. 32, Núm. 2, pp. 117-122

1999

  1. Maintenance of blood pressure control and left ventricular performance with small doses of enalapril

    American Journal of Cardiology, Vol. 83, Núm. 5, pp. 719-723

  2. Step-down of enalapril treatment for arterial hypertension

    Hypertension, Vol. 34, Núm. 6, pp. 1287-1292

1998

  1. Using low doses of enalapril maintains the reduction of QT and QTc dispersion achieved by prolonged treatment with higher doses

    Journal of Noninvasive Cardiology, Vol. 2, Núm. 6, pp. 28-34